InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Tuesday, 10/20/2020 10:39:36 PM

Tuesday, October 20, 2020 10:39:36 PM

Post# of 44690
HMMM, quick path changes, this is 9-27 $$ Raise. Then NRX partnering. Now, NRX to merge with NYSE 'pharma'. GEM to invest $150M.?.RLF $ to develop REL100.
Dr JJ says Trials going forward but what about current words of enrollments for the 3 Trials seen here and financed...GLTA...

"The available cash on the balance sheet of the Company, after receipt of the funds, will be approximately CHF 48,000,000 and will be used primarily to fund the ongoing Fast Track FDA trial of RLF-100 (IV) in COVID-19 acute respiratory distress syndrome (NCT04311697) and the RLF-100 (inhaled) trial for the treatment of non-acute lung injury in COVID-19 (NCT04360096) as well as to run a phase 3 study in Europe."



https://finance.yahoo.com/news/relief-announces-capital-increase-final-053000789.html